Intellipharmaceutics International Company Profile (NASDAQ:IPCI)

About Intellipharmaceutics International (NASDAQ:IPCI)

Intellipharmaceutics International logoIntellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: $29.86 million
  • Outstanding Shares: 30,573,000
Average Prices:
  • 50 Day Moving Avg: $1.01
  • 200 Day Moving Avg: $1.92
  • 52 Week Range: $0.81 - $3.35
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 3.69
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $4.36 million
  • Price / Sales: 6.47
  • Book Value: $0.03 per share
  • Price / Book: 35.50
Profitability:
  • EBIDTA: ($9,050,000.00)
  • Net Margins: -225.15%
  • Return on Equity: -867.02%
  • Return on Assets: -135.20%
Debt:
  • Current Ratio: 0.90%
  • Quick Ratio: 0.79%
Misc:
  • Average Volume: 345,739 shs.
  • Beta: 1.01
  • Short Ratio: 0.5
 

Frequently Asked Questions for Intellipharmaceutics International (NASDAQ:IPCI)

What is Intellipharmaceutics International's stock symbol?

Intellipharmaceutics International trades on the NASDAQ under the ticker symbol "IPCI."

How were Intellipharmaceutics International's earnings last quarter?

Intellipharmaceutics International Inc. (NASDAQ:IPCI) posted its quarterly earnings results on Thursday, October, 13th. The company reported ($0.07) EPS for the quarter, meeting the consensus estimate of ($0.07). The business had revenue of $0.56 million for the quarter, compared to analysts' expectations of $0.50 million. Intellipharmaceutics International had a negative net margin of 225.15% and a negative return on equity of 867.02%. View Intellipharmaceutics International's Earnings History.

When will Intellipharmaceutics International make its next earnings announcement?

Intellipharmaceutics International is scheduled to release their next quarterly earnings announcement on Thursday, October, 12th 2017. View Earnings Estimates for Intellipharmaceutics International.

Where is Intellipharmaceutics International's stock going? Where will Intellipharmaceutics International's stock price be in 2017?

3 brokerages have issued 12 month target prices for Intellipharmaceutics International's stock. Their predictions range from $2.00 to $8.00. On average, they expect Intellipharmaceutics International's stock price to reach $4.00 in the next twelve months. View Analyst Ratings for Intellipharmaceutics International.

What are analysts saying about Intellipharmaceutics International stock?

Here are some recent quotes from research analysts about Intellipharmaceutics International stock:

  • 1. According to Zacks Investment Research, "Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada. " (8/15/2017)
  • 2. Maxim Group analysts commented, "We note the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committees will hold discussions on the new drug application for Intellipharmaceutics’ abuse- deterrent oxycodone hydrochloride extended-release oral tablets (Rexista) on July 26, 2017. The committees will discuss the overall risk-benefit profile of Rexista and evaluate whether the abuse-deterrent properties of Rexista will be sufficient to support labeling." (7/21/2017)
  • 3. Aegis analysts commented, "We believe the stay is more likely to last longer than 30 months, as is typical in most patent dispute cases." (4/18/2017)

Who are some of Intellipharmaceutics International's key competitors?

Who are Intellipharmaceutics International's key executives?

Intellipharmaceutics International's management team includes the folowing people:

  • Isa Odidi Ph.D., Chairman of the Board, Chief Executive Officer
  • Amina Odidi Ph.D., President, Chief Operating Officer, Director
  • John N. Allport, Vice President - Legal Affairs and Licensing, Secretary, Director
  • Patrick N. Yat Ph.D., Vice President - Pharmaceutical Analysis and Chemistry
  • Kenneth Keirstead, Independent Director
  • Bahadur Madhani, Independent Director
  • Eldon R. Smith M.D., Independent Director

Who owns Intellipharmaceutics International stock?

Intellipharmaceutics International's stock is owned by many different of retail and institutional investors. Top institutional investors include Argent Trust Co (0.20%) and Advisor Group Inc. (0.16%). View Institutional Ownership Trends for Intellipharmaceutics International.

Who bought Intellipharmaceutics International stock? Who is buying Intellipharmaceutics International stock?

Intellipharmaceutics International's stock was purchased by a variety of institutional investors in the last quarter, including Argent Trust Co and Advisor Group Inc.. View Insider Buying and Selling for Intellipharmaceutics International.

How do I buy Intellipharmaceutics International stock?

Shares of Intellipharmaceutics International can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intellipharmaceutics International's stock price today?

One share of Intellipharmaceutics International stock can currently be purchased for approximately $0.92.


MarketBeat Community Rating for Intellipharmaceutics International (NASDAQ IPCI)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  173 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  279
MarketBeat's community ratings are surveys of what our community members think about Intellipharmaceutics International and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Intellipharmaceutics International (NASDAQ:IPCI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $4.00 (333.37% upside)

Analysts' Ratings History for Intellipharmaceutics International (NASDAQ:IPCI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/27/2017Maxim GroupLower Price TargetBuy -> Buy$6.00 -> $2.00HighView Rating Details
4/18/2017AegisReiterated RatingHold$2.00LowView Rating Details
10/17/2016Brean CapitalSet Price TargetBuy$8.00N/AView Rating Details
10/13/2015MackieSet Price TargetBuy$12.00N/AView Rating Details
(Data available from 9/19/2015 forward)

Earnings

Earnings History for Intellipharmaceutics International (NASDAQ:IPCI)
Earnings by Quarter for Intellipharmaceutics International (NASDAQ:IPCI)
Earnings History by Quarter for Intellipharmaceutics International (NASDAQ IPCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/12/2017        
10/13/2016Q316($0.07)($0.07)$0.50 million$0.56 millionViewN/AView Earnings Details
7/13/2016Q216($0.09)($0.08)$0.80 million$0.56 millionViewN/AView Earnings Details
4/14/2016Q1($0.07)($0.09)$0.70 million$0.57 millionViewN/AView Earnings Details
10/9/2015Q315($0.05)($0.08)$1.30 million$0.84 millionViewN/AView Earnings Details
7/13/2015Q215($0.05)($0.06)$1.20 million$1.27 millionViewN/AView Earnings Details
4/14/2015Q1 2015($0.08)($0.04)$1.20 million$1.14 millionViewN/AView Earnings Details
2/23/2015Q4 2014($0.07)($0.06)$1.40 million$1.54 millionViewN/AView Earnings Details
10/15/2014Q3($0.05)($0.07)$2.40 million$1.07 millionViewN/AView Earnings Details
4/14/2014Q114$0.11$0.09$4.49 million$4.70 millionViewN/AView Earnings Details
2/18/2014($0.08)($0.31)ViewN/AView Earnings Details
4/3/2013Q113($0.12)($0.07)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intellipharmaceutics International (NASDAQ:IPCI)
Current Year EPS Consensus Estimate: $-0.08 EPS
Next Year EPS Consensus Estimate: $0.25 EPS

Dividends

Dividend History for Intellipharmaceutics International (NASDAQ:IPCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intellipharmaceutics International (NASDAQ:IPCI)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Intellipharmaceutics International (NASDAQ:IPCI)
Latest Headlines for Intellipharmaceutics International (NASDAQ:IPCI)
Source:
DateHeadline
finance.yahoo.com logoDEADLINE APPROACHING: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 19 at 12:27 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders it Filed a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. and Set a Lead Plaintiff Deadline of September 29, 2017 -- IPCI
finance.yahoo.com - September 18 at 7:25 PM
finance.yahoo.com logoIPCI EXPANDED CLASS PERIOD: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intellipharmaceutics International Inc. and a Lead Plaintiff Deadline of September 29, 2017
finance.yahoo.com - September 16 at 2:05 AM
finance.yahoo.com logoDEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 16 at 2:05 AM
finance.yahoo.com logoEXPANDED CLASS: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. and Set a Lead Plaintiff Deadline of September 29, 2017 -- IPCI
finance.yahoo.com - September 15 at 1:51 AM
finance.yahoo.com logoDEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 15 at 1:51 AM
finance.yahoo.com logoIPCI EXPANDED CLASS: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intellipharmaceutics International Inc. and a Lead Plaintiff Deadline of September 29, 2017
finance.yahoo.com - September 14 at 6:30 AM
finance.yahoo.com logoSHAREHOLDER REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 14 at 6:30 AM
feeds.benzinga.com logoIPCI ALERT: Rosen Law Firm Reminds Intellipharmaceutics International Inc. Investors of Important Deadline in Class Action – IPCI
feeds.benzinga.com - September 13 at 7:43 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in IntelliPharmaCeutics International Inc. of Class Action Lawsuit and Upcoming Deadline - IPC
finance.yahoo.com - September 12 at 10:04 PM
finance.yahoo.com logoINVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) and Lead Plaintiff Deadline - September 29, 2017
finance.yahoo.com - September 12 at 4:41 PM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. and the Lead Plaintiff Deadline of September 29, 2017 -- IPCI
finance.yahoo.com - September 12 at 4:41 PM
finance.yahoo.com logoUPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 12 at 4:41 PM
finance.yahoo.com logoDEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 11 at 8:40 PM
businesswire.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Intellipharmaceutics International Inc ... - Business Wire (press release)
www.businesswire.com - September 10 at 12:21 AM
finance.yahoo.com logoAPPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 9 at 4:52 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) and Lead Plaintiff Deadline - September 29, 2017
finance.yahoo.com - September 8 at 11:52 PM
finance.yahoo.com logoUPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 8 at 11:52 PM
finance.yahoo.com logoIPCI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intellipharmaceutics International Inc. and a Lead Plaintiff Deadline of September 29, 2017
finance.yahoo.com - September 8 at 11:52 PM
finance.yahoo.com logoREAD NOW: Monteverde & Associates PC Reminds IntelliPharmaCeutics International Inc. Shareholders with Losses in Excess of $100,000 To Contact the Firm Immediately - IPCI
finance.yahoo.com - September 7 at 8:16 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Intellipharmaceutics International Inc. Shareholders and a Lead Plaintiff Deadline of September 29, 2017 (IPCI)
finance.yahoo.com - September 6 at 7:56 PM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 6 at 7:56 PM
rttnews.com logoMDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet
www.rttnews.com - September 6 at 2:46 AM
globenewswire.com logoIntellipharmaceutics Provides Operational Update Nasdaq:IPCI - GlobeNewswire (press release)
globenewswire.com - September 5 at 9:45 PM
finance.yahoo.com logoCorporate News Blog - Intellipharmaceutics International Announces Appointment of CFO
finance.yahoo.com - September 5 at 4:43 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - September 5 at 4:43 PM
finance.yahoo.com logoIntellipharmaceutics Provides Operational Update
finance.yahoo.com - September 5 at 4:43 PM
americanbankingnews.com logoIntellipharmaceutics International Inc. (IPCI) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - September 3 at 9:00 AM
americanbankingnews.com logoIntellipharmaceutics International Inc. (IPCI) Expected to Announce Quarterly Sales of $4.55 Million
www.americanbankingnews.com - September 3 at 8:48 AM
streetinsider.com logoIntellipharmaceutics (IPCI) Names Andrew Patient as CFO - StreetInsider.com
www.streetinsider.com - September 3 at 4:58 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) & Lead Plaintiff Deadline - September 29, 2017
finance.yahoo.com - September 2 at 6:49 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in IntelliPharmaCeutics International Inc. of Class Action Lawsuit and Upcoming Deadline
finance.yahoo.com - September 2 at 6:49 PM
globenewswire.com logoIntellipharmaceutics Appoints New Chief Financial Officer - GlobeNewswire (press release)
globenewswire.com - September 2 at 12:17 AM
americanbankingnews.com logoIntellipharmaceutics International Inc. (IPCI) Expected to Post Earnings of $0.01 Per Share
www.americanbankingnews.com - September 1 at 10:30 AM
globenewswire.com logoKahn Swick & Foti, LLC Announces Filing of Securities Fraud Class Action With An Extended Class Period Against ... - GlobeNewswire (press release)
globenewswire.com - September 1 at 1:01 AM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. and Set a Lead Plaintiff Deadline of September 29, 2017 -- IPCI
finance.yahoo.com - August 31 at 7:57 PM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 31 at 7:57 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Intellipharmaceutics International Inc. Shareholders and a Lead Plaintiff Deadline of September 29, 2017 (IPCI)
finance.yahoo.com - August 31 at 6:18 AM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 31 at 6:18 AM
finance.yahoo.com logoIPCI EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intellipharmaceutics International Inc. and a Lead Plaintiff Deadline of September 29, 2017
finance.yahoo.com - August 28 at 7:37 PM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against IntelliPharmaCeutics International Inc. (IPCI) & Lead Plaintiff Deadline - September 29, 2017
finance.yahoo.com - August 28 at 7:37 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 28 at 7:37 PM
finance.yahoo.com logoSHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in IntelliPharmaCeutics International Inc. of Class Action Lawsuit and Upcoming Deadline – IPCI
finance.yahoo.com - August 26 at 7:08 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 26 at 2:55 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Intellipharmaceutics International Inc. and Set a Lead Plaintiff Deadline of September 29, 2017 -- IPCI
finance.yahoo.com - August 25 at 4:44 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 25 at 7:09 AM
finance.yahoo.com logoThe Klein Law Firm Notifies Investors of a Class Action Filed on Behalf of Intellipharmaceutics International Inc. Shareholders and a Lead Plaintiff Deadline of September 29, 2017 (IPCI)
finance.yahoo.com - August 24 at 8:01 AM
americanbankingnews.com logoGalena Biopharma (GALE) & Intellipharmaceutics International (IPCI) Head to Head Review
www.americanbankingnews.com - August 23 at 10:22 PM
globenewswire.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against ... - GlobeNewswire (press release)
globenewswire.com - August 23 at 5:44 AM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against IntelliPharmaCeutics International Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - August 23 at 5:44 AM

Social

Chart

Intellipharmaceutics International (IPCI) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by MarketBeat.com Staff